Table of Contents
1 Industry Overview of Neurodegenerative Diseases
 1.1 Definition and Specifications of Neurodegenerative Diseases
    1.1.1 Definition of Neurodegenerative Diseases
    1.1.2 Specifications of Neurodegenerative Diseases
 1.2 Classification of Neurodegenerative Diseases
 1.3 Applications of Neurodegenerative Diseases
 1.4 Industry Chain Structure of Neurodegenerative Diseases
 1.5 Industry Overview and Major Regions Status of Neurodegenerative Diseases
    1.5.1 Industry Overview of Neurodegenerative Diseases
    1.5.2 Global Major Regions Status of Neurodegenerative Diseases
 1.6 Industry Policy Analysis of Neurodegenerative Diseases
 1.7 Industry News Analysis of Neurodegenerative Diseases2 Manufacturing Cost Structure Analysis of Neurodegenerative Diseases
 2.1 Raw Material Suppliers and Price Analysis of Neurodegenerative Diseases
 2.2 Equipment Suppliers and Price Analysis of Neurodegenerative Diseases
 2.3 Labor Cost Analysis of Neurodegenerative Diseases
 2.4 Other Costs Analysis of Neurodegenerative Diseases
 2.5 Manufacturing Cost Structure Analysis of Neurodegenerative Diseases
 2.6 Manufacturing Process Analysis of Neurodegenerative Diseases3 3 Global Market Size (Volume and Value), Sales and Sale Price Analysis of Neurodegenerative Diseases
 3.1 Global Market Size (Volume and Value) and Growth Rate of Neurodegenerative Diseases 2011-2016
 3.2 Global Market Size (Volume and Value) of Neurodegenerative Diseases by Regions 2011-2016
 3.3 Global Market Size (Volume and Value) of Neurodegenerative Diseases by Types 2011-2016
 3.4 Global Market Size (Volume and Value) of Neurodegenerative Diseases by Applications 2011-2016
 3.5 Global Sales Volume and Sales Revenue of Neurodegenerative Diseases by Companies 2011-2016
 3.6 Global Sale Price of Neurodegenerative Diseases by Regions 2011-2016
 3.7 Global Sale Price of Neurodegenerative Diseases by Types 2011-2016
 3.8 Global Sale Price of Neurodegenerative Diseases by Applications 2011-2016
 3.9 Global Sale Price of Neurodegenerative Diseases by Companies 2011-20164 USA Market Size (Volume and Value), Sales, Sale Price and End Users Analysis of Neurodegenerative Diseases
 4.1 USA Market Size (Volume and Value) and Growth Rate of Neurodegenerative Diseases 2011-2016
 4.2 USA Market Size (Volume and Value) of Neurodegenerative Diseases by Types 2011-2016
 4.3 USA Market Size (Volume and Value) of Neurodegenerative Diseases by Applications 2011-2016
 4.4 USA Sales Volume and Sales Revenue of Neurodegenerative Diseases by Companies 2011-2016
 4.5 USA Sale Price of Neurodegenerative Diseases by Types 2011-2016
 4.6 USA Sale Price of Neurodegenerative Diseases by Applications 2011-2016
 4.7 USA Sale Price of Neurodegenerative Diseases by Companies 2011-2016
 4.8 USA Regional Supply, Import, Export and Consumption of Neurodegenerative Diseases 2011-2016
 4.9 USA End Users with Contact Information and Consumption Volume of Neurodegenerative Diseases by Applications5 Europe Market Size (Volume and Value), Sales, Sale Price and End Users Analysis of Neurodegenerative Diseases
 5.1 Europe Market Size (Volume and Value) and Growth Rate of Neurodegenerative Diseases 2011-2016
 5.2 Europe Market Size (Volume and Value) of Neurodegenerative Diseases by Types 2011-2016
 5.3 Europe Market Size (Volume and Value) of Neurodegenerative Diseases by Applications 2011-2016
 5.4 Europe Sales Volume and Sales Revenue of Neurodegenerative Diseases by Companies 2011-2016
 5.5 Europe Sale Price of Neurodegenerative Diseases by Types 2011-2016
 5.6 Europe Sale Price of Neurodegenerative Diseases by Applications 2011-2016
 5.7 Europe Sale Price of Neurodegenerative Diseases by Companies 2011-2016
 5.8 Europe Regional Supply, Import, Export and Consumption of Neurodegenerative Diseases 2011-2016
 5.9 Europe End Users with Contact Information and Consumption Volume of Neurodegenerative Diseases by Applications6 China Market Size (Volume and Value), Sales, Sale Price and End Users Analysis of Neurodegenerative Diseases
 6.1 China Market Size (Volume and Value) and Growth Rate of Neurodegenerative Diseases 2011-2016
 6.2 China Market Size (Volume and Value) of Neurodegenerative Diseases by Types 2011-2016
 6.3 China Market Size (Volume and Value) of Neurodegenerative Diseases by Applications 2011-2016
 6.4 China Sales Volume and Sales Revenue of Neurodegenerative Diseases by Companies 2011-2016
 6.5 China Sale Price of Neurodegenerative Diseases by Types 2011-2016
 6.6 China Sale Price of Neurodegenerative Diseases by Applications 2011-2016
 6.7 China Sale Price of Neurodegenerative Diseases by Companies 2011-2016
 6.8 China Regional Supply, Import, Export and Consumption of Neurodegenerative Diseases 2011-2016
 6.9 China End Users with Contact Information and Consumption Volume of Neurodegenerative Diseases by Applications7 Japan Market Size (Volume and Value), Sales, Sale Price and End Users Analysis of Neurodegenerative Diseases
 7.1 Japan Market Size (Volume and Value) and Growth Rate of Neurodegenerative Diseases 2011-2016
 7.2 Japan Market Size (Volume and Value) of Neurodegenerative Diseases by Types 2011-2016
 7.3 Japan Market Size (Volume and Value) of Neurodegenerative Diseases by Applications 2011-2016
 7.4 Japan Sales Volume and Sales Revenue of Neurodegenerative Diseases by Companies 2011-2016
 7.5 Japan Sale Price of Neurodegenerative Diseases by Types 2011-2016
 7.6 Japan Sale Price of Neurodegenerative Diseases by Applications 2011-2016
 7.7 Japan Sale Price of Neurodegenerative Diseases by Companies 2011-2016
 7.8 Japan Regional Supply, Import, Export and Consumption of Neurodegenerative Diseases 2011-2016
 7.9 Japan End Users with Contact Information and Consumption Volume of Neurodegenerative Diseases by Applications8 Major Manufacturers Analysis of Neurodegenerative Diseases
 8.1 Biogen Idec
    8.1.1 Company Profile
    8.1.2 Product Picture and Specifications
        8.1.2.1 Type I
        8.1.2.2 Type II
        8.1.2.3 Type III
    8.1.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.1.4 Contact Information 8.2 Merck Serono
    8.2.1 Company Profile
    8.2.2 Product Picture and Specifications
        8.2.2.1 Type I
        8.2.2.2 Type II
        8.2.2.3 Type III
    8.2.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.2.4 Contact Information
 8.3 Novartis
    8.3.1 Company Profile
    8.3.2 Product Picture and Specifications
        8.3.2.1 Type I
        8.3.2.2 Type II
        8.3.2.3 Type III
    8.3.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.3.4 Contact Information
 8.4 Pfizer
    8.4.1 Company Profile
    8.4.2 Product Picture and Specifications
        8.4.2.1 Type I
        8.4.2.2 Type II
        8.4.2.3 Type III
    8.4.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.4.4 Contact Information
 8.5 Teva Pharmaceutical Industries
    8.5.1 Company Profile
    8.5.2 Product Picture and Specifications
        8.5.2.1 Type I
        8.5.2.2 Type II
        8.5.2.3 Type III
    8.5.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.5.4 Contact Information
 8.6 UCB
    8.6.1 Company Profile
    8.6.2 Product Picture and Specifications
        8.6.2.1 Type I
        8.6.2.2 Type II
        8.6.2.3 Type III
    8.6.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.6.4 Contact Information
 8.7 AB Science
    8.7.1 Company Profile
    8.7.2 Product Picture and Specifications
        8.7.2.1 Type I
        8.7.2.2 Type II
        8.7.2.3 Type III
    8.7.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.7.4 Contact Information
 8.8 Abbvie
    8.8.1 Company Profile
    8.8.2 Product Picture and Specifications
        8.8.2.1 Type I
        8.8.2.2 Type II
        8.8.2.3 Type III
    8.8.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.8.4 Contact Information
 8.9 Acorda Therapeutics
    8.9.1 Company Profile
    8.9.2 Product Picture and Specifications
        8.9.2.1 Type I
        8.9.2.2 Type II
        8.9.2.3 Type III
    8.9.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.9.4 Contact Information
 8.10 Actavis
    8.10.1 Company Profile
    8.10.2 Product Picture and Specifications
        8.10.2.1 Type I
        8.10.2.2 Type II
        8.10.2.3 Type III
    8.10.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.10.4 Contact Information
 8.11 Active Biotech
    8.11.1 Company Profile
    8.11.2 Product Picture and Specifications
        8.11.2.1 Type I
        8.11.2.2 Type II
        8.11.2.3 Type III
    8.11.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.11.4 Contact Information
 8.12 Adamas Pharmaceuticals
    8.12.1 Company Profile
    8.12.2 Product Picture and Specifications
        8.12.2.1 Type I
        8.12.2.2 Type II
        8.12.2.3 Type III
    8.12.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.12.4 Contact Information
 8.13 Akorn
    8.13.1 Company Profile
    8.13.2 Product Picture and Specifications
        8.13.2.1 Type I
        8.13.2.2 Type II
        8.13.2.3 Type III
    8.13.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.13.4 Contact Information
 8.14 Archer Pharmaceuticals
    8.14.1 Company Profile
    8.14.2 Product Picture and Specifications
        8.14.2.1 Type I
        8.14.2.2 Type II
        8.14.2.3 Type III
    8.14.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.14.4 Contact Information
 8.15 Astellas
    8.15.1 Company Profile
    8.15.2 Product Picture and Specifications
        8.15.2.1 Type I
        8.15.2.2 Type II
        8.15.2.3 Type III
    8.15.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.15.4 Contact Information
 8.16 Auspex Pharmaceuticals
    8.16.1 Company Profile
    8.16.2 Product Picture and Specifications
        8.16.2.1 Type I
        8.16.2.2 Type II
        8.16.2.3 Type III
    8.16.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.16.4 Contact Information
 8.17 Bayer
    8.17.1 Company Profile
    8.17.2 Product Picture and Specifications
        8.17.2.1 Type I
        8.17.2.2 Type II
        8.17.2.3 Type III
    8.17.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.17.4 Contact Information
 8.18 Boehringer Ingelheim
    8.18.1 Company Profile
    8.18.2 Product Picture and Specifications
        8.18.2.1 Type I
        8.18.2.2 Type II
        8.18.2.3 Type III
    8.18.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.18.4 Contact Information
 8.19 Covis
    8.19.1 Company Profile
    8.19.2 Product Picture and Specifications
        8.19.2.1 Type I
        8.19.2.2 Type II
        8.19.2.3 Type III
    8.19.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.19.4 Contact Information
 8.20 Desitin Arzneimittel
    8.20.1 Company Profile
    8.20.2 Product Picture and Specifications
        8.20.2.1 Type I
        8.20.2.2 Type II
        8.20.2.3 Type III
    8.20.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.20.4 Contact Information
 8.21 Eisai
    8.21.1 Company Profile
    8.21.2 Product Picture and Specifications
        8.21.2.1 Type I
        8.21.2.2 Type II
        8.21.2.3 Type III
    8.21.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.21.4 Contact Information
 8.22 Eli Lilly
    8.22.1 Company Profile
    8.22.2 Product Picture and Specifications
        8.22.2.1 Type I
        8.22.2.2 Type II
        8.22.2.3 Type III
    8.22.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.22.4 Contact Information
 8.23 Endo International
    8.23.1 Company Profile
    8.23.2 Product Picture and Specifications
        8.23.2.1 Type I
        8.23.2.2 Type II
        8.23.2.3 Type III
    8.23.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.23.4 Contact Information
    8.24 F. Hoffmann-La Roche
    8.24.1 Company Profile
    8.24.2 Product Picture and Specifications
        8.24.2.1 Type I
        8.24.2.2 Type II
        8.24.2.3 Type III
    8.24.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.24.4 Contact Information
9 Global Production Analysis of Neurodegenerative Diseases by Regions
 9.1 Global Production of Neurodegenerative Diseases by Regions 2011-2016
 9.2 Global Production Market Share of Neurodegenerative Diseases by Regions 2011-201610 Global and Major Regions Market Size (Volume and Value) Forecast of Neurodegenerative Diseases
 10.1 Global and Major Regions Market Size (Volume and Value) and Growth Rate of Neurodegenerative Diseases 2016-2021
 10.2 Global Market Size (Volume and Value) of Neurodegenerative Diseases by Regions 2016-2021
 10.3 Global and Major Regions Market Size (Volume and Value) of Neurodegenerative Diseases by Types 2016-2021
 10.4 Global and Major Regions Market Size (Volume and Value) of Neurodegenerative Diseases by Applications 2016-202111 Marketing Trader or Distributor Analysis of Neurodegenerative Diseases
 11.1 Marketing Channels Status of Neurodegenerative Diseases
 11.2 Traders or Distributors with Contact Information of Neurodegenerative Diseases by Regions
 11.3 Regional Import, Export and Trade Analysis of Neurodegenerative Diseases12 New Project Investment Feasibility Analysis of Neurodegenerative Diseases
 12.1 New Project SWOT Analysis of Neurodegenerative Diseases
 12.2 New Project Investment Feasibility Analysis of Neurodegenerative Diseases13 Conclusion of the Global Neurodegenerative Diseases Consumption 2016 Market Research Report